chelsea-35 ed cyproterone acetate 2 mg and ethinylestradiol 35 micrograms tablet blister pack
aspen pharma pty ltd - cyproterone acetate,ethinylestradiol -
cyprocur 100 cyproterone acetate 100mg tablet blister pack
aspen pharma pty ltd - cyproterone acetate -
aspen adrenaline injection adrenaline (epinephrine) 1 mg/10 ml solution for injection ampoule
aspen pharmacare australia pty ltd - adrenaline (epinephrine), quantity: 1 mg - injection, solution - excipient ingredients: tartaric acid; sodium metabisulfite; sodium chloride; water for injections; dilute hydrochloric acid; sodium hydroxide - an adjunct in the management of cardiac arrest.
butamol 5 salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
aspen pharma pty ltd - salbutamol sulfate -
butamol 2.5 salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
aspen pharma pty ltd - salbutamol sulfate -
aspecillin v phenoxymethylpenicillin (as benzathine) 150mg/5ml oral liquid, suspension bottle
aspen pharma pty ltd - phenoxymethylpenicillin benzathine -
apo-ipratropium ipratropium bromide anhydrous 500 microgram/ml inhalation ampoule
aspen pharma pty ltd - ipratropium bromide monohydrate -
apo-ipratropium ipratropium bromide anhydrous 250 microgram/ml inhalation ampoule
aspen pharma pty ltd - ipratropium bromide monohydrate -
myambutol ethambutol hydrochloride 400mg tablet
aspen pharma pty ltd - ethambutol hydrochloride, quantity: 400 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; gelatin; calcium hydrogen phosphate dihydrate; maize starch; ethylcellulose; sorbitol; titanium dioxide; macrogol 6000 - indications as at 04 jan 2002 : oral administation : myambutol is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculois meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculous of the shin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjuction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs - myambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 months for example, myambutol plus isoniazid plus rifampicin or myambutol plus isoniazid plus streptomycin then continuing with a two drug regimen such as myambutol plus isoniazid or myambutol plus rifampicin. in patients who have received previous antituberculosis therapy, mycobacterial resistance to other durgs used in initial therapy is frequent. consequently, in such retreatment cases myambutol should be combined with at least one of the second-line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculosis drugs used with myambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been use in multiple drug regimens. alternating drug regimens have also been utilised.
eutroxsig levothyroxine sodium 75 micrograms tablet blister pack
aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; dextrin; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.